IRIS Accounts Production v24.3.2.46 00982587 Board of Directors 1.7.23 30.6.24 30.6.24 false true false false true false 73 73 48090 48137 26 73 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh009825872023-06-30009825872024-06-30009825872023-07-012024-06-30009825872022-06-30009825872022-07-012023-06-30009825872023-06-3000982587ns15:EnglandWales2023-07-012024-06-3000982587ns14:PoundSterling2023-07-012024-06-3000982587ns10:Director12023-07-012024-06-3000982587ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3000982587ns10:SmallEntities2023-07-012024-06-3000982587ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3000982587ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3000982587ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3000982587ns10:FullAccounts2023-07-012024-06-3000982587ns10:Director2422023-06-3000982587ns10:Director2422022-06-3000982587ns10:Director2422023-07-012024-06-3000982587ns10:Director2422024-06-3000982587ns10:Director2422023-06-3000982587ns10:Director22023-07-012024-06-3000982587ns10:Director32023-07-012024-06-3000982587ns10:CompanySecretary12023-07-012024-06-3000982587ns10:RegisteredOffice2023-07-012024-06-3000982587ns5:CurrentFinancialInstruments2024-06-3000982587ns5:CurrentFinancialInstruments2023-06-3000982587ns5:ShareCapital2024-06-3000982587ns5:ShareCapital2023-06-3000982587ns5:RetainedEarningsAccumulatedLosses2024-06-3000982587ns5:RetainedEarningsAccumulatedLosses2023-06-3000982587ns5:LeaseholdImprovements2023-07-012024-06-3000982587ns5:PlantMachinery2023-07-012024-06-3000982587ns5:FurnitureFittings2023-07-012024-06-3000982587ns5:ComputerEquipment2023-07-012024-06-3000982587ns5:LeaseholdImprovements2023-06-3000982587ns5:PlantMachinery2023-06-3000982587ns5:FurnitureFittings2023-06-3000982587ns5:ComputerEquipment2023-06-3000982587ns5:LeaseholdImprovements2024-06-3000982587ns5:PlantMachinery2024-06-3000982587ns5:FurnitureFittings2024-06-3000982587ns5:ComputerEquipment2024-06-3000982587ns5:LeaseholdImprovements2023-06-3000982587ns5:PlantMachinery2023-06-3000982587ns5:FurnitureFittings2023-06-3000982587ns5:ComputerEquipment2023-06-3000982587ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3000982587ns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-3000982587ns5:DeferredTaxation2023-06-3000982587ns5:DeferredTaxation2024-06-3000982587ns5:RetainedEarningsAccumulatedLosses2023-06-3000982587ns5:RetainedEarningsAccumulatedLosses2023-07-012024-06-30009825871ns10:Director12023-06-30009825871ns10:Director12022-06-30009825871ns10:Director12023-07-012024-06-30009825871ns10:Director12022-07-012023-06-30009825871ns10:Director12024-06-30009825871ns10:Director12023-06-30009825873ns10:Director32023-06-30009825873ns10:Director32022-06-30009825873ns10:Director32023-07-012024-06-30009825873ns10:Director32022-07-012023-06-30009825873ns10:Director32024-06-30009825873ns10:Director32023-06-30
REGISTERED NUMBER: 00982587 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 June 2024

for

Kenex (Electro-Medical) Limited

Kenex (Electro-Medical) Limited (Registered number: 00982587)






Contents of the Financial Statements
for the Year Ended 30 June 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Kenex (Electro-Medical) Limited

Company Information
for the Year Ended 30 June 2024







DIRECTORS: KC Hunt
Mrs SK Hunt
PA Hunt





SECRETARY: Mrs S Hunt





REGISTERED OFFICE: Unit 17
RO24 Greenway
Harlow Business Park
Harlow
Essex
CM19 5QB





REGISTERED NUMBER: 00982587 (England and Wales)





ACCOUNTANTS: Lawrence & Company
26 Bell Street
Sawbridgeworth
Hertfordshire
CM21 9AN

Kenex (Electro-Medical) Limited (Registered number: 00982587)

Balance Sheet
30 June 2024

30.6.24 30.6.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 377,642 415,764

CURRENT ASSETS
Stocks 1,325,833 1,321,262
Debtors 5 1,729,239 1,834,370
Investments 6 86,211 78,342
Cash at bank and in hand 3,368,196 2,156,888
6,509,479 5,390,862
CREDITORS
Amounts falling due within one year 7 743,516 714,056
NET CURRENT ASSETS 5,765,963 4,676,806
TOTAL ASSETS LESS CURRENT
LIABILITIES

6,143,605

5,092,570

PROVISIONS FOR LIABILITIES 8 9,115 8,689
NET ASSETS 6,134,490 5,083,881

CAPITAL AND RESERVES
Called up share capital 3,500 3,500
Retained earnings 9 6,130,990 5,080,381
SHAREHOLDERS' FUNDS 6,134,490 5,083,881

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Kenex (Electro-Medical) Limited (Registered number: 00982587)

Balance Sheet - continued
30 June 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18 September 2024 and were signed on its behalf by:





KC Hunt - Director


Kenex (Electro-Medical) Limited (Registered number: 00982587)

Notes to the Financial Statements
for the Year Ended 30 June 2024

1. STATUTORY INFORMATION

Kenex (Electro-Medical) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - Straight line over 20 years
Plant and machinery - 20% on reducing balance
Fixtures and fittings - 15% on reducing balance
Computer equipment - 33% on reducing balance and 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Foreign currencies
Assets and liabilities denominated in foreign currencies are translated at the rate of exchange ruling at the balance sheet date. Tranactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All differences are taken to the profit and loss account.

Kenex (Electro-Medical) Limited (Registered number: 00982587)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 23 (2023 - 25 ) .

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and Computer
property machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 July 2023 559,281 26,426 130,105 88,353 804,165
Additions - - 2,155 - 2,155
At 30 June 2024 559,281 26,426 132,260 88,353 806,320
DEPRECIATION
At 1 July 2023 196,407 20,593 88,996 82,405 388,401
Charge for year 28,970 1,167 8,653 1,487 40,277
At 30 June 2024 225,377 21,760 97,649 83,892 428,678
NET BOOK VALUE
At 30 June 2024 333,904 4,666 34,611 4,461 377,642
At 30 June 2023 362,874 5,833 41,109 5,948 415,764

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.24 30.6.23
£    £   
Trade debtors 1,578,210 1,675,833
Other debtors 105,866 114,809
Prepayments 45,163 43,728
1,729,239 1,834,370

6. CURRENT ASSET INVESTMENTS
30.6.24 30.6.23
£    £   
Listed investments 86,211 78,342

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.24 30.6.23
£    £   
Trade creditors 164,179 264,010
Tax 512,308 383,525
Social security and other taxes 42,423 43,222
Directors' current accounts 1,715 3,828
Accrued expenses 22,891 19,471
743,516 714,056

Kenex (Electro-Medical) Limited (Registered number: 00982587)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024

8. PROVISIONS FOR LIABILITIES
30.6.24 30.6.23
£    £   
Deferred tax 9,115 8,689

Deferred
tax
£   
Balance at 1 July 2023 8,689
Transfer to deferred tax 426
Balance at 30 June 2024 9,115

9. RESERVES
Retained
earnings
£   

At 1 July 2023 5,080,381
Profit for the year 1,985,143
Dividends (942,403 )
Gain on listed investment 7,869
At 30 June 2024 6,130,990

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 June 2024 and 30 June 2023:

30.6.24 30.6.23
£    £   
KC Hunt and Mrs SK Hunt
Balance outstanding at start of year (73 ) (73 )
Amounts advanced (48,090 ) -
Amounts repaid 48,137 -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (26 ) (73 )

PA Hunt
Balance outstanding at start of year (3,755 ) (95 )
Amounts advanced - (4,500 )
Amounts repaid 2,066 840
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (1,689 ) (3,755 )

11. RELATED PARTY DISCLOSURES

During the year, total dividends of £942,403 (2023 - £1,181,949) were paid to the directors .

Kenex (Electro-Medical) Limited (Registered number: 00982587)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024

11. RELATED PARTY DISCLOSURES - continued

The ultimate controlling parties are Mr KC & Mrs SK Hunt, the two directors who own 100% of the voting share capital, as with similar organisations of this size and nature, they have a directors loan account that funds flow in and out of, the movements during the year are summarised above.